Skip to main content
Caplight Logo









Lyfegen

Lyfegen

Private
BaselHealthcare & Life Scienceshttps://www.lyfegen.com/

Last Round

Series A

Extension

Dec 11, 2024

Total Funding Raised

$16.64M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Lyfegen is a health tech company that provides a software platform for access, pricing, and rebate management for health insurances, governments, and pharmaceutical companies.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Healthcare Analytics, Compliance & Risk, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

value-based contractingdrug pricingoutcome-based pricingrebate managementhealthcare SaaSpharma techhealthcare analyticscontract automationreal-world evidenceRWEpayer-provider solutionshealth techvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lyfegen Comparables

Compare Lyfegen with similar companies based on industry and business-model similarity.

Lyfegen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Model N
68%
Datavant
67%
Accorded
66%

Lyfegen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 11, 2024
Series ASep 20, 2022
SeedSep 1, 2020
SeedApr 17, 2019

Key People

Founding team and executive leadership

Nico Julian Mros

Chief Customer Experience Officer & Founder

Founding Team

Girisha Fernando

CEO Founder

Founding Team

Lyfegen Investors

Notable investors and investment history

Lyfegen investors
InvestorRounds
APEX VenturesSeries A
aMoonSeries A Extension, Series A
TX VenturesSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 115% MoM, reaching 4.7K.

  • Mar 3, 2026

    Launched AI Contracting Companion for drug access solutions.

Lyfegen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lyfegen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lyfegen's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range51
Year Founded2018
Last FundingDec 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?